More About: Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast Carcinoma
Open Access
- 19 January 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 92 (2) , 161-162
- https://doi.org/10.1093/jnci/92.2.161
Abstract
Axelsson et al. (1) reported in this Journal that microvessel density (MVD) in 220 breast cancers did not provide prognostic information for metastasis-free or overall survival; this result was contrary to most published series (2). The study was designed to assess the reliability of MVD to predict the outcome for patients with breast cancer. MVD was measured by two observers who independently selected and scored the three most vascular fields. The maximum MVD was used for survival analysis (1).Keywords
This publication has 8 references indexed in Scilit:
- COMMENTARY Tumour angiogenesis and prognosisHistopathology, 1997
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Re: Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast CarcinomaJNCI Journal of the National Cancer Institute, 1995
- ResponseJNCI Journal of the National Cancer Institute, 1995
- Re: Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Re: Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysisThe Journal of Pathology, 1995
- Tumor Angiogenesis as a Prognostic Assay for Invasive Ductal Breast CarcinomaJNCI Journal of the National Cancer Institute, 1995